Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has submitted a routine compliance certificate to BSE for the quarter ended December 31, 2025, as required under SEBI's Depositories and Participants Regulations. The certificate was issued by the company's Registrar and Share Transfer Agent, M/s Venture Capital and Corporate Investments Private Limited (SEBI Reg. No. INR000001203). It confirms that share certificates received for dematerialization were properly cancelled, mutilated, and the depository's name (NSDL/CDSL) was updated in the company's records as the registered owner within the mandated 15-day timeline. No financial figures or operational updates are included.
This is a standard procedural filing with no impact on the company's financials, operations, or stock price. It merely confirms the company's RTA is complying with share dematerialization rules.